KKR & Co LP, often abbreviated as KKR, is an internationally renowned leading private equity and global investment firm that has built a reputation for delivering premier investment solutions and strategies. It is mainly recognized for its complex and high-profile acquisitions. Incorporated in 1976 by the famous duo, Henry R. Kravis and George R. Roberts, the firm flaunts a rich history rooted in innovation, deep industry expertise and long-term focus.
Based in New York City, KKR manages a multi-strategy investment pool, with billions of dollars in assets in private equity, energy, infrastructure, real estate, credit strategies, and hedge funds. It operates by purchasing undervalued or struggling companies, improving them, and then selling them for a profit. By doing so, KKR proves its strength in creating sustainable value and driving meaningful growth.
KKR's operations expanded from the U.S market to the global scale over the years. The firm currently extends its operations across North America, Europe, Asia, and Australia through its offices in 20 cities around the world. Among their most notable transactions in history was the acquisition of RJR Nabisco in 1989, the biggest leveraged buyout to date, subject of the book (and movie adaptation) "Barbarians at the Gate".
Investors in KKR funds comprise a broad range of institutions, individuals and entities, including pension plans, sovereign wealth funds, foundations, endowments, corporations, and professional investment funds.
Moreover, the company is committed to responsible investment practices. It has incorporated Environmental, Social, and Governance (ESG) considerations into its decision-making process since 2008, reflecting its integrated approach to value creation.
KKR is also listed publicly on the New York Stock Exchange and currently manages approximately $429 billion in assets, as per December 31, 2021. Despite the economic turbulence caused by the COVID-19 pandemic, KKR demonstrated resilience, thanks to its diversified business model and exceptional talent pool, ensuring continued returns for investors.
Combining financial resources, operational expertise, and industry knowledge, KKR continues to transform businesses and create superior returns for its investors. Therefore, KKR & Co remains not only a titan in the world of private equity but a powerful global investment firm.
Income statement
Balance sheet statement
Cash flow statement
Current assets / Current liabilities
Equity / Debt / Cash
Dividends
Mount Logan Capital Inc. announced its financial results for the third quarter ended September 30, 2026, reporting year-to-date Segment Income of $11.5 million, an increase of 21% year-over-year. The company highlighted strategic transactions completed during the quarter, including SOFIX's asset acquisition and the merger of the Alternative Credit Income Fund, which are expected to add $6.5 million of annualized Fee-Related Earnings. Mount Logan also declared a quarterly distribution of $0.03 per share of common stock.
Realty Income (NYSE:O) reported solid third-quarter earnings, with adjusted funds from operations (AFFO) up 3.7% to $1.12 per share, and raised its 2026 AFFO guidance. The company, known for its consistent monthly dividends, paid out about 73% of its AFFO and made significant investments in new properties. Its diversified tenant base and high occupancy rates underpin its durable business model, reinforcing its appeal as a dependable dividend stock.
Realty Income, a leading dividend stock, recently reported its third-quarter earnings, showing a 3.7% increase in adjusted funds from operations (AFFO) to $1.12 per share and raised its 2026 AFFO guidance. The company has a consistent track record of 676 consecutive monthly dividends, supported by a diversified tenant base and high occupancy rates across its 15,500 commercial properties. This stable business model prioritizes dependable income and dividend growth over explosive share-price appreciation.
Shares of KKR & Co. Inc. fell 2.06% to $95.99 on Tuesday, underperforming the S&P 500 Index which rose 0.36%, and the Dow Jones Industrial Average which fell 0.38%. The company's stock closed 33.73% below its 52-week high of $144.84, reached on December 11th.
Keefe, Bruyette & Woods has reduced its price target for KKR Real Estate Finance Trust (NYSE:KREF) from $6.50 to $5.50, while maintaining a "market perform" rating, suggesting a potential upside of 4.46%. The company currently holds an average "Hold" rating from analysts with an average price target of $8.67, and institutional investors own approximately 70.23% of its stock. KREF shares opened at $5.26 and are near their 52-week low of $4.93, reflecting cautious analyst sentiment.
Thomson Reuters (NASDAQ: TRI) reported third-quarter earnings and revenue below analyst estimates but raised its fiscal 2026 sales guidance, with its stock rising in premarket trading. The company's updated outlook excludes its Global Print business and projects increased total and organic revenue growth, along with a higher adjusted EBITDA margin. This positive revision is largely attributed to the growing momentum of its AI initiatives, including the CoCounsel Legal and Tax platforms, and increased generative AI content licensing revenue at Reuters.
Rhythm Pharmaceuticals (Nasdaq: RYTM) announced strong Q3 2026 financial results, with global net product revenue from IMCIVREE reaching $92.1 million, a 29% increase from the prior quarter, driven by strong U.S. launch momentum and the commercial launch in Japan. The company also reported over 700 patient start forms for IMCIVREE in acquired hypothalamic obesity (HO) and detailed the advancement of bivamelagon into pivotal development for Prader-Willi syndrome. Additionally, Rhythm secured a five-year term loan facility for up to $750 million and amended its licensing agreement with LG Chem for bivamelagon.
Rhythm Pharmaceuticals has amended its exclusive license agreement with LG Chem for bivamelagon, securing fixed payments of $350 million over four years and a 1% royalty. This agreement coincides with Rhythm Pharmaceuticals obtaining a $750 million term loan from KKR and Blackstone. The news highlights a significant financial restructuring and partnership update for the biotechnology company.